Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy
AbstarctPage 95, Table 2, final row, second column: the mean Advanced treatment annual cost which
Source: PharmacoEconomics - Category: Health Management Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Health Management | HER2 | Herceptin | Iran Health | Middle East Health